Abdominal obesity and other risk factors largely explain the high CRP in Indigenous Australians relative to the general population, but not gender differences: A cross-sectional study

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Hodge, Allison M ^a   Maple Brown, Louise ^b,c   Cunningham, Joan ^b   Boyle, Jacqueline ^b   Dunbar, Terry ^d   Weeramanthri, Tarun ^e   Shaw, Jonathan ^f   O'Dea, Kerin ^g  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c ROYAL DARWIN HOSPITAL   (Australia)

^d CHARLES DARWIN UNIVERSITY   (Australia)

^e DEPARTMENT OF HEALTH   (Australia)

^f BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^g UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL FAT; ABORIGINE; ADULT; ARTICLE; AUSTRALIA; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; ETHNOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; RISK FACTOR;

ABDOMINAL FAT; ADULT; AUSTRALIA; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; OCEANIC ANCESTRY GROUP; RISK FACTORS;

EID: 78149427575     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-700     Document Type: Article

References (34)

1. Interleukin-6 and chronic inflammation. C Gabay, Arthritis research & therapy 2006 8 Suppl 2 3
2. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. S Kaptoge E Di Angelantonio G Lowe MB Pepys SG Thompson R Collins J Danesh, Lancet 2010 375 132 140 10.1016/S0140-6736(09)61717-7 20031199
3. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. A Onat G Can G Hergenc, Metabolism: clinical and experimental 2008 57 207 214 18191050
4. Differential association of C-reactive protein with adiposity in men and women in an Aboriginal community in northeast Arnhem Land of Australia. T Shemesh KG Rowley A Jenkins J Brimblecombe JD Best K O'Dea, International journal of obesity (2005) 2007 31 103 108 10.1038/sj.ijo.0803350 16682979
5. Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. J Hung MW Knuiman ML Divitini T Davis JP Beilby, The American journal of cardiology 2008 101 193 198 10.1016/j.amjcard.2007.07. 061 18178405
6. Increased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease. LJ Maple-Brown LS Piers MF O'Rourke DS Celermajer K O'Dea, Journal of hypertension 2007 25 585 591 10.1097/HJH. 0b013e328011f766 17278975
7. Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. K Rowley KZ Walker J Cohen AJ Jenkins D O'Neal Q Su JD Best K O'Dea, The Medical journal of Australia 2003 178 495 500 12741936
8. Distribution and correlates of C-reactive protein concentrations among adult US women. ES Ford WH Giles AH Mokdad GL Myers, Clinical chemistry 2004 50 574 581 10.1373/clinchem.2003.027359 14709450
9. Race and gender differences in C-reactive protein levels. A Khera DK McGuire SA Murphy HG Stanek SR Das W Vongpatanasin FH Wians Jr SM Grundy JA de Lemos, Journal of the American College of Cardiology 2005 46 464 469 10.1016/j.jacc.2005.04.051 16053959
10. Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome. O Rogowski I Shapira S Berliner, Metabolism: clinical and experimental 2008 57 1221 1226 18702947
11. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. MK Rutter JB Meigs LM Sullivan RB D'Agostino Sr PW Wilson, Circulation 2004 110 380 385 10.1161/01.CIR.0000136581.59584.0E 15262834
12. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School Cohort Study. S Yamada T Gotoh Y Nakashima K Kayaba S Ishikawa N Nago Y Nakamura Y Itoh E Kajii, American journal of epidemiology 2001 153 1183 1190 10.1093/aje/153.12.1183 11415953
13. C-reactive protein: associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. M Woodward A Rumley GD Lowe H Tunstall-Pedoe, British journal of haematology 2003 122 135 141 10.1046/j.1365-2141.2003.04387.x 12823355
14. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. A Nazmi CG Victora, BMC public health 2007 7 212 10.1186/1471-2458-7-212 17705867
15. Early-life and adult socioeconomic status and inflammatory risk markers in adulthood. RA Pollitt JS Kaufman KM Rose AV Diez-Roux D Zeng G Heiss, European journal of epidemiology 2007 22 55 66 10.1007/s10654-006-9082-1 17225957
16. Effects of socioeconomic position on inflammatory and hemostatic markers: a life-course analysis in the 1958 British birth cohort. F Tabassum M Kumari A Rumley G Lowe C Power DP Strachan, American journal of epidemiology 2008 167 1332 1341 10.1093/aje/kwn055 18367468
17. Study protocol - diabetes and related conditions in urban indigenous people in the Darwin, Australia region: aims, methods and participation in the DRUID Study. J Cunningham K O'Dea T Dunbar T Weeramanthri P Zimmet J Shaw, BMC public health 2006 6 8 10.1186/1471-2458-6-8 16417641
18. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. DJ Magliano EL Barr PZ Zimmet AJ Cameron DW Dunstan S Colagiuri D Jolley N Owen P Phillips RJ Tapp, et al. Diabetes care 2008 31 267 272 10.2337/dc07-0912 17989310
19. Definition, Diagnosis and Classification of Diabetes Mellitus and It's Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. World Health Organization, Geneva: World Health Organization, Department of Noncommunicable Disease Surveillance 1999
20. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) - methods and response rates. DW Dunstan PZ Zimmet TA Welborn AJ Cameron J Shaw M de Courten D Jolley DJ McCarty, Diabetes research and clinical practice 2002 57 119 129 10.1016/S0168-8227(02)00025-6 12062857
21. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. TA Pearson GA Mensah RW Alexander JL Anderson RO Cannon M Criqui YY Fadl SP Fortmann Y Hong GL Myers, et al. Circulation 2003 107 499 511 10.1161/01.CIR.0000052939.59093.45 12551878
22. C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian aboriginal cohort. T Shemesh KG Rowley AJ Jenkins JD Best K O'Dea, Clinical chemistry 2009 55 336 341 10.1373/clinchem.2008.115360 19074519
23. Obesity. Preventing and Managing the epidemic. World Health Organization, Geneva: World Health Organization 1997
24. Population distribution of high sensitivity C-reactive protein values in Aboriginal Australians: a comparison with other populations. Z Wang WE Hoy, Clinical biochemistry 2006 39 277 281 10.1016/j.clinbiochem.2005.11.016 16405882
25. Association of C-reactive protein and metabolic syndrome in a rural Chinese population. J Wen Y Liang F Wang L Sun Y Guo X Duan X Liu Q Tao TY Wong X Lu, et al. Clinical biochemistry 2009 42 976 983 10.1016/j.clinbiochem.2009. 03.026 19358836
26. Sex differences in the relationship between C-reactive protein and body fat. A Khera GL Vega SR Das C Ayers DK McGuire SM Grundy JA de Lemos, J Clin Endocrinol Metab 2009 94 3251 3258 10.1210/jc.2008-2406 19567538
27. Coronary artery disease: Are men and women created equal? A Blum N Blum, Gend Med 2009 6 410 418 10.1016/j.genm.2009.09.005 19850237
28. C-Reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: insights from the Genetics of Coronary Artery Disease in Alaska Natives (GOCADAN) study. BV Howard L Best A Comuzzie SO Ebbesson SE Epstein RR Fabsitz WJ Howard A Silverman H Wang J Zhu, et al. Diabetes care 2008 31 2312 2314 10.2337/dc08-0815 18796618
29. Prevalence of Helicobacter pylori in Indigenous Western Australians: comparison between urban and remote rural populations. HM Windsor EA Abioye-Kuteyi JM Leber SD Morrow MK Bulsara BJ Marshall, The Medical journal of Australia 2005 182 210 213 15748129
30. The burden and outcome of respiratory tract infection in Australian and aboriginal children. AJ Leach PS Morris, The Pediatric infectious disease journal 2007 26 4 7 10.1097/INF.0b013e318154b238 18049380
31. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community. S McDonald G Maguire N Duarte XL Wang W Hoy, Clin Sci (Lond) 2004 106 121 128 10.1042/CS20030186 12956621
32. Does high C-reactive protein concentration increase atherosclerosis? The Whitehall II Study. M Kivimaki DA Lawlor GD Smith M Kumari A Donald A Britton JP Casas T Shah E Brunner NJ Timpson, et al. PloS one 2008 3 3013 10.1371/journal.pone.0003013 18714381
33. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. WL Roberts L Moulton TC Law G Farrow M Cooper-Anderson J Savory N Rifai, Clinical chemistry 2001 47 418 425 11238291
34. C-reactive protein genetics is associated with carotid artery compliance in men in The Cardiovascular Risk in Young Finns Study. C Eklund M Kivimaki MS Islam M Juonala M Kahonen J Marniemi T Lehtimaki J Viikari OT Raitakari M Hurme, Atherosclerosis 2008 196 841 848 10.1016/j.atherosclerosis.2007.01.027 17350021